Download PDF
Semin Neurol 2022; 42(02): 158-167
DOI: 10.1055/s-0041-1742266
Review Article

Neuropsychiatric Treatments for Parkinson's Disease: Nonpharmacological Approaches

Neha Mathur
1   Integrated Movement Disorders Program, Toronto Rehabilitation Institute, University Health Network, Toronto, Ontario, Canada
,
Haseel Bhatt
1   Integrated Movement Disorders Program, Toronto Rehabilitation Institute, University Health Network, Toronto, Ontario, Canada
2   Edmond J. Safra Program in Parkinson's Disease and the Morton and Gloria Shulman Movement Disorders Clinic, Department of Medicine, Division of Neurology Toronto Western Hospital and the University of Toronto, Toronto, Ontario, Canada
,
Sarah C. Lidstone 
1   Integrated Movement Disorders Program, Toronto Rehabilitation Institute, University Health Network, Toronto, Ontario, Canada
2   Edmond J. Safra Program in Parkinson's Disease and the Morton and Gloria Shulman Movement Disorders Clinic, Department of Medicine, Division of Neurology Toronto Western Hospital and the University of Toronto, Toronto, Ontario, Canada
› Author Affiliations Funding This work was supported in part by an anonymous donation to the Toronto Western Hospital Movement Disorders Clinic.
› Further Information
    Permissions and Reprints

Abstract

Although diagnosed by characteristic motor features, Parkinson's disease and other movement disorders are frequently accompanied by a wide range of neuropsychiatric symptoms that require a multidisciplinary approach for treatment. Neuropsychiatric symptoms such as depression, anxiety and cognitive symptoms strongly influence quality of life, motor symptoms, and non-motor bodily symptoms. This review summarizes our current understanding of the neuropsychiatric symptoms in movement disorders and discusses the evidence base for treatments focusing on rehabilitation and nonpharmacological approaches. A practical approach is then proposed for patient selection for specific treatments based on disease stage. The article focuses mostly on Parkinson's disease as a prototypical movement disorder with the largest evidence base but the principles discussed herein are applicable to a range of other movement disorders.

Keywords

Parkinson's disease - movement disorders - psychotherapy - rehabilitation - multidisciplinary - physiotherapy - mind–body - nonpharmacological treatment


Publication History

Article published online:
03 February 2022

© 2022. Thieme. All rights reserved.

Thieme Medical Publishers, Inc.
333 Seventh Avenue, 18th Floor, New York, NY 10001, USA

 

  • References

  • 1 Marsden CD. Movement disorders in neuropsychiatry. In: Reynolds EH, Trimble MR. eds. The Bridge between Neurology and Psychiatry. Edinburgh: Churchill Livingstone; 1989
    Google Scholar
  • 2 Weintraub D, Burn DJ. Parkinson's disease: the quintessential neuropsychiatric disorder. Mov Disord 2011; 26 (06) 1022-1031
    CrossrefPubMedGoogle Scholar
  • 3 Kuhlman GD, Flanigan JL, Sperling SA, Barrett MJ. Predictors of health-related quality of life in Parkinson's disease. Parkinsonism Relat Disord 2019; 65: 86-90
    CrossrefPubMedGoogle Scholar
  • 4 Santos García D, de Deus Fonticoba T, Suárez Castro E. et al; Coppadis Study Group. Non-motor symptoms burden, mood, and gait problems are the most significant factors contributing to a poor quality of life in non-demented Parkinson's disease patients: results from the COPPADIS study cohort. Parkinsonism Relat Disord 2019; 66: 151-157
    CrossrefPubMedGoogle Scholar
  • 5 Vlaanderen FP, Rompen L, Munneke M, Stoffer M, Bloem BR, Faber MJ. The voice of the Parkinson customer. J Parkinsons Dis 2019; 9 (01) 197-201
    CrossrefPubMedGoogle Scholar
  • 6 Lyketsos CG, Kozauer N, Rabins PV. Psychiatric manifestations of neurologic disease: where are we headed?. Dialogues Clin Neurosci 2007; 9 (02) 111-124
    CrossrefPubMedGoogle Scholar
  • 7 Poewe W, Seppi K, Tanner CM. et al. Parkinson disease. Nat Rev Dis Primers 2017; 3: 17013
    CrossrefPubMedGoogle Scholar
  • 8 Dorsey ER, Constantinescu R, Thompson JP. et al. Projected number of people with Parkinson disease in the most populous nations, 2005 through 2030. Neurology 2007; 68 (05) 384-386
    CrossrefPubMedGoogle Scholar
  • 9 Carrozzino D, Morberg BM, Siri C, Pezzoli G, Bech P. Evaluating psychiatric symptoms in Parkinson's Disease by a clinimetric analysis of the Hopkins Symptom Checklist (SCL-90-R). Prog Neuropsychopharmacol Biol Psychiatry 2018; 81: 131-137
    CrossrefPubMedGoogle Scholar
  • 10 Forbes EJ, Byrne GJ, O'Sullivan JD, Yang J, Marsh R, Dissanayaka NN. Defining atypical anxiety in Parkinson's disease. Mov Disord Clin Pract (Hoboken) 2021; 8 (04) 571-581
    CrossrefPubMedGoogle Scholar
  • 11 Nuti A, Ceravolo R, Piccinni A. et al. Psychiatric comorbidity in a population of Parkinson's disease patients. Eur J Neurol 2004; 11 (05) 315-320
    CrossrefPubMedGoogle Scholar
  • 12 Dissanayaka NNW, O'Sullivan JD, Pachana NA. et al. Disease-specific anxiety symptomatology in Parkinson's disease. Int Psychogeriatr 2016; 28 (07) 1153-1163
    CrossrefPubMedGoogle Scholar
  • 13 Quelhas R, Costa M. Anxiety, depression, and quality of life in Parkinson's disease. J Neuropsychiatry Clin Neurosci 2009; 21 (04) 413-419
    CrossrefPubMedGoogle Scholar
  • 14 Veazey C, Aki SOE, Cook KF, Lai EC, Kunik ME. Prevalence and treatment of depression in Parkinson's disease. J Neuropsychiatry Clin Neurosci 2005; 17 (03) 310-323
    CrossrefPubMedGoogle Scholar
  • 15 Han JW, Ahn YD, Kim W-S. et al. Psychiatric manifestation in patients with Parkinson's disease. J Korean Med Sci 2018; 33 (47) e300
    CrossrefPubMedGoogle Scholar
  • 16 Schrag A, Jahanshahi M, Quinn N. What contributes to quality of life in patients with Parkinson's disease?. J Neurol Neurosurg Psychiatry 2000; 69 (03) 308-312
    CrossrefPubMedGoogle Scholar
  • 17 Broen MPG, Narayen NE, Kuijf ML, Dissanayaka NNW, Leentjens AFG. Prevalence of anxiety in Parkinson's disease: a systematic review and meta-analysis. Mov Disord 2016; 31 (08) 1125-1133
    CrossrefPubMedGoogle Scholar
  • 18 Pontone GM, Williams JR, Anderson KE. et al. Prevalence of anxiety disorders and anxiety subtypes in patients with Parkinson's disease. Mov Disord 2009; 24 (09) 1333-1338
    CrossrefPubMedGoogle Scholar
  • 19 Schneider RB, Iourinets J, Richard IH. Parkinson's disease psychosis: presentation, diagnosis and management. Neurodegener Dis Manag 2017; 7 (06) 365-376
    CrossrefPubMedGoogle Scholar
  • 20 Pagonabarraga J, Kulisevsky J, Strafella AP, Krack P. Apathy in Parkinson's disease: clinical features, neural substrates, diagnosis, and treatment. Lancet Neurol 2015; 14 (05) 518-531
    CrossrefPubMedGoogle Scholar
  • 21 Loas G, Krystkowiak P, Godefroy O. Anhedonia in Parkinson's disease: an overview. J Neuropsychiatry Clin Neurosci 2012; 24 (04) 444-451
    CrossrefPubMedGoogle Scholar
  • 22 den Brok MGHE, van Dalen JW, van Gool WA, Moll van Charante EP, de Bie RMA, Richard E. Apathy in Parkinson's disease: a systematic review and meta-analysis. Mov Disord 2015; 30 (06) 759-769
    CrossrefPubMedGoogle Scholar
  • 23 Mele B, Van S, Holroyd-Leduc J, Ismail Z, Pringsheim T, Goodarzi Z. Diagnosis, treatment and management of apathy in Parkinson's disease: a scoping review. BMJ Open 2020; 10 (09) e037632
    CrossrefPubMedGoogle Scholar
  • 24 Kelly MJ, Baig F, Hu MT-M, Okai D. Spectrum of impulse control behaviours in Parkinson's disease: pathophysiology and management. J Neurol Neurosurg Psychiatry 2020; 91 (07) 703-711
    CrossrefPubMedGoogle Scholar
  • 25 Eggers C, Dano R, Schill J, Fink GR, Hellmich M, Timmermann L. CPN study group. Patient-centered integrated healthcare improves quality of life in Parkinson's disease patients: a randomized controlled trial. J Neurol 2018; 265 (04) 764-773
    CrossrefPubMedGoogle Scholar
  • 26 Monticone M, Ambrosini E, Laurini A, Rocca B, Foti C. In-patient multidisciplinary rehabilitation for Parkinson's disease: a randomized controlled trial. Mov Disord 2015; 30 (08) 1050-1058
    CrossrefPubMedGoogle Scholar
  • 27 Ferrazzoli D, Ortelli P, Zivi I. et al. Efficacy of intensive multidisciplinary rehabilitation in Parkinson's disease: a randomised controlled study. J Neurol Neurosurg Psychiatry 2018; 89 (08) 828-835
    CrossrefPubMedGoogle Scholar
  • 28 Frazzitta G, Maestri R, Bertotti G. et al. Intensive rehabilitation treatment in early Parkinson's disease: a randomized pilot study with a 2-year follow-up. Neurorehabil Neural Repair 2015; 29 (02) 123-131
    CrossrefPubMedGoogle Scholar
  • 29 Hong C-T, Tan S, Huang T-W. Psychotherapy for the Treatment of Anxiety and Depression in Patients with Parkinson Disease: A Meta-Analysis of Randomized Controlled Trials. J Am Med Dir Assoc 2021; 22 (11) 2289-2295.e2
    CrossrefPubMedGoogle Scholar
  • 30 Fernie BA, Kollmann J, Brown RG. Cognitive behavioural interventions for depression in chronic neurological conditions: a systematic review. J Psychosom Res 2015; 78 (05) 411-419
    CrossrefPubMedGoogle Scholar
  • 31 Yang S, Sajatovic M, Walter BL. Psychosocial interventions for depression and anxiety in Parkinson's disease. J Geriatr Psychiatry Neurol 2012; 25 (02) 113-121
    CrossrefPubMedGoogle Scholar
  • 32 Zhang Q, Yang X, Song H, Jin Y. Cognitive behavioral therapy for depression and anxiety of Parkinson's disease: a systematic review and meta-analysis. Complement Ther Clin Pract 2020; 39: 101111
    CrossrefPubMedGoogle Scholar
  • 33 Lopes SR, Khan S, Chand S. The growing role of cognitive behavior therapy in the treatment of Parkinson's disease. J Geriatr Psychiatry Neurol 2021; 34 (04) 310-320
    CrossrefPubMedGoogle Scholar
  • 34 Koychev I, Okai D. Cognitive-behavioural therapy for non-motor symptoms of Parkinson's disease: a clinical review. Evid Based Ment Health 2017; 20 (01) 15-20
    CrossrefPubMedGoogle Scholar
  • 35 Okai D, Askey-Jones S, Samuel M. et al. Trial of CBT for impulse control behaviors affecting Parkinson patients and their caregivers. Neurology 2013; 80 (09) 792-799
    CrossrefPubMedGoogle Scholar
  • 36 Okai D, Askey-Jones S, Samuel M, David AS, Brown RG. Predictors of response to a cognitive behavioral intervention for impulse control behaviors in Parkinson's disease. Mov Disord 2015; 30 (05) 736-739
    CrossrefPubMedGoogle Scholar
  • 37 Dissanayaka NNW, Idu Jion F, Pachana NA. et al. Mindfulness for motor and nonmotor dysfunctions in Parkinson's disease. Parkinsons Dis 2016; 2016: 7109052
    PubMedGoogle Scholar
  • 38 Fitzpatrick L, Simpson J, Smith A. A qualitative analysis of mindfulness-based cognitive therapy (MBCT) in Parkinson's disease. Psychol Psychother 2010; 83 (Pt 2): 179-192
    CrossrefPubMedGoogle Scholar
  • 39 Xie C-L, Wang X-D, Chen J. et al. A systematic review and meta-analysis of cognitive behavioral and psychodynamic therapy for depression in Parkinson's disease patients. Neurol Sci 2015; 36 (06) 833-843
    CrossrefPubMedGoogle Scholar
  • 40 Dobkin RD, Mann SL, Gara MA, Interian A, Rodriguez KM, Menza M. Telephone-based cognitive behavioral therapy for depression in Parkinson disease: a randomized controlled trial. Neurology 2020; 94 (16) e1764-e1773
    CrossrefPubMedGoogle Scholar
  • 41 Kraepelien M, Schibbye R, Månsson K, Sundström C, Riggare S, Andersson G. et al. Individually tailored internet-based cognitive-behavioral therapy for daily functioning in patients with Parkinson's disease: a randomized controlled trial. J Park Dis 2020; 10 (02) 653-664
    PubMedGoogle Scholar
  • 42 Deuel LM, Seeberger LC. Complementary Therapies in Parkinson Disease: a Review of Acupuncture, Tai Chi, Qi Gong, Yoga, and Cannabis. Neurotherapeutics 2020; 17 (04) 1434-1455
    CrossrefPubMedGoogle Scholar
  • 43 La Forge R. Mind-Body (Mindful) Exercise in Practice. ACSM's Health Fit J 2016; 20 (04) 6-8
    CrossrefPubMedGoogle Scholar
  • 44 Greeson JM, Chin GR. Mindfulness and physical disease: a concise review. Curr Opin Psychol 2019; 28: 204-210
    CrossrefPubMedGoogle Scholar
  • 45 Chen S, Zhang Y, Wang YT, Liu X, Song W, Du X. The effect of Qigong-based therapy on patients with Parkinson's disease: a systematic review and meta-analysis. Clin Rehabil 2020; 34 (12) 1436-1448
    CrossrefPubMedGoogle Scholar
  • 46 Song R, Grabowska W, Park M. et al. The impact of Tai Chi and Qigong mind-body exercises on motor and non-motor function and quality of life in Parkinson's disease: a systematic review and meta-analysis. Parkinsonism Relat Disord 2017; 41: 3-13
    CrossrefPubMedGoogle Scholar
  • 47 Ni X, Liu S, Lu F, Shi X, Guo X. Efficacy and safety of Tai Chi for Parkinson's disease: a systematic review and meta-analysis of randomized controlled trials. PLoS One 2014; 9 (06) e99377
    CrossrefPubMedGoogle Scholar
  • 48 Sharma NK, Robbins K, Wagner K, Colgrove YM. A randomized controlled pilot study of the therapeutic effects of yoga in people with Parkinson's disease. Int J Yoga 2015; 8 (01) 74-79
    CrossrefPubMedGoogle Scholar
  • 49 Van Puymbroeck M, Walter AA, Hawkins BL. et al. Functional improvements in Parkinson's disease following a randomized trial of Yoga. Evid Based Complement Alternat Med 2018; 2018: 8516351
    PubMedGoogle Scholar
  • 50 Cheung C, Bhimani R, Wyman JF. et al. Effects of yoga on oxidative stress, motor function, and non-motor symptoms in Parkinson's disease: a pilot randomized controlled trial. Pilot Feasibility Stud 2018; 4: 162
    CrossrefPubMedGoogle Scholar
  • 51 Jin X, Wang L, Liu S, Zhu L, Loprinzi PD, Fan X. The impact of mind-body exercises on motor function, depressive symptoms, and quality of life in Parkinson's disease: a systematic review and meta-analysis. Int J Environ Res Public Health 2019; 17 (01) 31
    CrossrefPubMedGoogle Scholar
  • 52 Hasan SM, Alshafie S, Hasabo EA. et al. Efficacy of dance for Parkinson's disease: a pooled analysis of 372 patients. J Neurol 2021
    PubMedGoogle Scholar
  • 53 Hackney ME, Earhart GM. Effects of dance on movement control in Parkinson's disease: a comparison of Argentine tango and American ballroom. J Rehabil Med 2009; 41 (06) 475-481
    CrossrefPubMedGoogle Scholar
  • 54 Cochen De Cock V, Dotov D, Damm L. et al. BeatWalk: personalized music-based gait rehabilitation in Parkinson's disease. Front Psychol 2021; 12: 655121
    CrossrefPubMedGoogle Scholar
  • 55 Chandler SK, Robins JL, Kinser PA. Nonpharmacologic interventions for the self-management of anxiety in Parkinson's disease: a comprehensive review. Behav Neurol 2019; 2019: 8459579
    CrossrefPubMedGoogle Scholar
  • 56 Abbruzzese G, Marchese R, Avanzino L, Pelosin E. Rehabilitation for Parkinson's disease: current outlook and future challenges. Parkinsonism Relat Disord 2016; 22 (Suppl. 01) S60-S64
    CrossrefPubMedGoogle Scholar
  • 57 World Health Organization (WHO). Rehabilitation. 2021 Accessed August 20, 2021 at: https://www.who.int/health-topics/rehabilitation
    PubMedGoogle Scholar
  • 58 Tomlinson CL, Herd CP, Clarke CE. et al. Physiotherapy for Parkinson's disease: a comparison of techniques. Cochrane Movement Disorders Group, editor. Cochrane Database Syst Rev. June 17, 2014. Accessed October 01, 2021 at: https://doi.wiley.com/10.1002/14651858.CD002815.pub2
    PubMedGoogle Scholar
  • 59 Mak MK, Wong-Yu IS, Shen X, Chung CL. Long-term effects of exercise and physical therapy in people with Parkinson disease. Nat Rev Neurol 2017; 13 (11) 689-703
    CrossrefPubMedGoogle Scholar
  • 60 Mehrholz J, Kugler J, Storch A, Pohl M, Hirsch K, Elsner B. Treadmill training for patients with Parkinson's disease. Cochrane Movement Disorders Group, editor. Cochrane Database Syst Rev. Sep 13, 2015. Accessed October 01, 2021 at: https://doi.wiley.com/10.1002/14651858.CD007830.pub4
    PubMedGoogle Scholar
  • 61 Radder DLM, Nonnekes J, van Nimwegen M. et al. Recommendations for the organization of multidisciplinary clinical care teams in Parkinson's disease. J Parkinsons Dis 2020; 10 (03) 1087-1098
    CrossrefPubMedGoogle Scholar
  • 62 Lidstone SC, Bayley M, Lang AE. The evidence for multidisciplinary care in Parkinson's disease. Expert Rev Neurother 2020; 20 (06) 539-549
    CrossrefPubMedGoogle Scholar
  • 63 Qamar MA, Harington G, Trump S, Johnson J, Roberts F, Frost E. Multidisciplinary care in Parkinson's disease. Int Rev Neurobiol 2017; 132: 511-523
    CrossrefPubMedGoogle Scholar
  • 64 Keus S, Munneke M, Graziano M, Paltamaa J, Pelosin E, Domingos J. et al. European Physiotherapy Guideline for Parkinson's Disease. Nijmegen: KNGF/ParkinsonNet; 2014: 191
    Google Scholar
  • 65 Keus SHJ, Hendriks HJM, Bloem BR. et al. Guidelines for physical therapy in patients with Parkinson's disease. Dutch J Physiother 2004; 114 (03) ):supplement 1-94
    PubMedGoogle Scholar
  • 66 Sturkenboom I, Thijssen M, Elsacker JG. et al. Guidelines for Occupational Therapy in Parkinson's Disease Rehabilitation. Nijmegen: ParkinsonNet/NPF; 2011
    Google Scholar
  • 67 Aragon A, Kings J. College of Occupational Therapists, Specialist Section Neurological Practice. Occupational Therapy for People with Parkinson's Disease: Best Practice Guidelines. London: College of Occupational Therapists; 2010
    Google Scholar
  • 68 Kalf J, de Swart B, Bloem BR, Munneke M. 3.414 Guidelines for speech–language therapy in Parkinson's disease. Parkinsonism Relat Disord 2007; 13: S183-S184 DOI: 10.1016/S1353-8020(08)70916-7.
    CrossrefPubMedGoogle Scholar
  • 69 Ypinga JHL, de Vries NM, Boonen LHHM. et al. Effectiveness and costs of specialised physiotherapy given via ParkinsonNet: a retrospective analysis of medical claims data. Lancet Neurol 2018; 17 (02) 153-161
    CrossrefPubMedGoogle Scholar
  • 70 American College of Sports Medicine. Riebe D, Ehrman JK, Liguori G, Magal M. ACSM's Guidelines for Exercise Testing and Prescription. 11th ed.. Philadelphia, PA: Lippincott Williams & Wilkins; 2021
    Google Scholar
  • 71 Rafferty MR, Nettnin E, Goldman JG, MacDonald J. Frameworks for Parkinson's disease rehabilitation addressing when, what, and how. Curr Neurol Neurosci Rep 2021; 21 (03) 12
    CrossrefPubMedGoogle Scholar
  • 72 Radder DLM, Lígia Silva de Lima A, Domingos J. et al. Physiotherapy in Parkinson's disease: a meta-analysis of present treatment modalities. Neurorehabil Neural Repair 2020; 34 (10) 871-880
    CrossrefPubMedGoogle Scholar
  • 73 Gillespie LD, Robertson MC, Gillespie WJ. et al. Interventions for preventing falls in older people living in the community. Cochrane Database Syst Rev v 2012; (09) Art. No: CD007146
    PubMedGoogle Scholar
  • 74 Foster ER, Carson LG, Archer J, Hunter EG. Occupational therapy interventions for instrumental activities of daily living for adults with Parkinson's disease: a systematic review. Am J Occup Ther 2021; 75 (03) 7503190030
    CrossrefPubMedGoogle Scholar
  • 75 Levy ES, Moya-Galé G, Chang YHM. et al. The effects of intensive speech treatment on intelligibility in Parkinson's disease: a randomised controlled trial. EClinicalMedicine 2020; 24: 100429
    CrossrefPubMedGoogle Scholar
  • 76 Beck EN, Wang MTY, Intzandt BN, Almeida QJ, Ehgoetz Martens KA. Sensory focused exercise improves anxiety in Parkinson's disease: a randomized controlled trial. PLOS ONE 2020; Apr 16; 15 (04) e0230803
    CrossrefPubMedGoogle Scholar
  • 77 Wu P-L, Lee M, Huang T-T. Effectiveness of physical activity on patients with depression and Parkinson's disease: a systematic review. PLOS ONE 2017; Jul 27; 12 (07) e0181515
    CrossrefPubMedGoogle Scholar
  • 78 Diederich NJ, Pieri V, Goetz CG. Coping strategies for visual hallucinations in Parkinson's disease. Mov Disord 2003; 18 (07) 831-832
    CrossrefPubMedGoogle Scholar
  • 79 Cugusi L, Solla P, Serpe R. et al. Effects of a Nordic Walking program on motor and non-motor symptoms, functional performance and body composition in patients with Parkinson's disease. NeuroRehabilitation 2015; 37 (02) 245-254
    CrossrefPubMedGoogle Scholar
  • 80 Frazzitta G, Bertotti G, Riboldazzi G. et al. Effectiveness of intensive inpatient rehabilitation treatment on disease progression in parkinsonian patients: a randomized controlled trial with 1-year follow-up. Neurorehabil Neural Repair 2012; 26 (02) 144-150
    CrossrefPubMedGoogle Scholar
  • 81 Ellis T, Katz DI, White DK, DePiero TJ, Hohler AD, Saint-Hilaire M. Effectiveness of an inpatient multidisciplinary rehabilitation program for people with Parkinson disease. Phys Ther 2008; 88 (07) 812-819
    CrossrefPubMedGoogle Scholar
  • 82 Schenkman M, Moore CG, Kohrt WM. et al. Effect of high-intensity treadmill exercise on motor symptoms in patients with de novo Parkinson disease: a phase 2 randomized clinical trial. JAMA Neurol 2018; 75 (02) 219-226
    CrossrefPubMedGoogle Scholar
  • 83 Guo L, Jiang Y, Yatsuya H, Yoshida Y, Sakamoto J. Group education with personal rehabilitation for idiopathic Parkinson's disease. Can J Neurol Sci 2009; 36 (01) 51-59
    CrossrefPubMedGoogle Scholar
  • 84 A'Campo LEI, Wekking EM, Spliethoff-Kamminga NGA, Le Cessie S, Roos RAC. The benefits of a standardized patient education program for patients with Parkinson's disease and their caregivers. Parkinsonism Relat Disord 2010; 16 (02) 89-95
    CrossrefPubMedGoogle Scholar
  • 85 Choudhury TK, Harris C, Crist K, Satterwhite TK, York MK. Comparative patient satisfaction and feasibility of a pilot Parkinson's disease enrichment program. J Geriatr Psychiatry Neurol 2017; 30 (05) 253-260
    CrossrefPubMedGoogle Scholar
  • 86 Lindskov S, Westergren A, Hagell P. A controlled trial of an educational programme for people with Parkinson's disease. J Clin Nurs 2007; 16 (11C, 11c): 368-376
    CrossrefPubMedGoogle Scholar
  • 87 Sunvisson H, Ekman S-L, Hagberg H, Lökk J. An education programme for individuals with Parkinson's disease. Scand J Caring Sci 2001; 15 (04) 311-317
    CrossrefPubMedGoogle Scholar
  • 88 Brittle N, Brown M, Mant J, McManus R, Riddoch J, Sackley C. Short-term effects on mobility, activities of daily living and health-related quality of life of a Conductive Education programme for adults with multiple sclerosis, Parkinson's disease and stroke. Clin Rehabil 2008; 22 (04) 329-337
    CrossrefPubMedGoogle Scholar
  • 89 Ghielen I, Rutten S, Boeschoten RE. et al. The effects of cognitive behavioral and mindfulness-based therapies on psychological distress in patients with multiple sclerosis, Parkinson's disease and Huntington's disease: two meta-analyses. J Psychosom Res 2019; 122: 43-51
    CrossrefPubMedGoogle Scholar
  • 90 Nijkrake MJ, Keus SHJ, Oostendorp RAB. et al. Allied health care in Parkinson's disease: referral, consultation, and professional expertise. Mov Disord 2009; 24 (02) 282-286
    CrossrefPubMedGoogle Scholar
  • 91 Grimes D, Fitzpatrick M, Gordon J. et al. Canadian guideline for Parkinson disease. CMAJ 2019; 191 (36) E989-E1004
    CrossrefPubMedGoogle Scholar
  • 92 National Institute for Health and Care Excellence. Nonpharmacological management of motor and non-motor symptoms. In: NICE guideline: Parkinson's disease in adults. National Institute for Health and Care Excellence. 2017. Accessed September 23, 2021 at: https://www.nice.org.uk/guidance/ng71/chapter/Recommendations#nonpharmacological-management-of-motor-and-non-motorsymptoms
    PubMedGoogle Scholar
  • 93 Soundy A, Stubbs B, Roskell C. The experience of Parkinson's disease: a systematic review and meta-ethnography. ScientificWorldJournal 2014; 2014: 613592
    CrossrefPubMedGoogle Scholar
  • 94 Clarke CE, Patel S, Ives N. et al. Clinical effectiveness and cost-effectiveness of physiotherapy and occupational therapy versus no therapy in mild to moderate Parkinson's disease: a large pragmatic randomised controlled trial(PD REHAB). Health Technol Assess 2016; 20 (63) 1-96
    CrossrefPubMedGoogle Scholar
  • 95 Kaseda Y, Ikeda J, Sugihara K, Yamawaki T, Kohriyama T, Matsumoto M. Therapeutic effects of intensive inpatient rehabilitation in advanced Parkinson's disease. Neurol Clin Neurosci 2017; 5 (01) 18-21
    CrossrefPubMedGoogle Scholar
  • 96 Miyasaki JM, Kluger B. Palliative care for Parkinson's disease: has the time come?. Curr Neurol Neurosci Rep 2015; 15 (05) 26
    CrossrefPubMedGoogle Scholar
  • 97 Hoehn MM, Yahr MD. Parkinsonism: onset, progression and mortality. Neurology 1967; 17 (05) 427-442
    CrossrefPubMedGoogle Scholar